Although the hypoxia-inducible factor 1A (HIF1A) pathway is crucial in HCC progression, its regulatory mechanisms remain unclear as mutations in its primary regulator, von Hippel-Lindau tumor suppressor (<i>VHL</i>), are rare in HCC. Here, VHL is linked to hepatocellular carcinoma.